Oramed Pharmaceuticals, Inc. (ORMP)
3.285
-0.12
(-3.67%)
USD |
NASDAQ |
Mar 06, 16:00
3.28
0.00 (0.00%)
After-Hours: 20:00
Oramed Pharmaceuticals Cash from Investing (Quarterly) : 38.82M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Lifeward Ltd. | 0.00 |
| Bristol Myers Squibb Co. | -1.458B |
| Merck & Co., Inc. | -11.20B |
| Instil Bio, Inc. | 8.447M |
| Moderna, Inc. | -48.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.991M |
| Cash from Financing (Quarterly) | -0.3928M |
| Free Cash Flow | -11.03M |
| Free Cash Flow Per Share (Quarterly) | -0.0466 |
| Free Cash Flow to Equity (Quarterly) | -1.940M |
| Free Cash Flow to Firm (Quarterly) | -1.992M |
| Free Cash Flow Yield | -8.06% |